|
| 35477676 | Hot flash clinical trial baseline measurements: how long is needed? | BMJ Support Palliat Care | 2024 |
| 37867114 | Sexual Dysfunction in Patients With Metastatic Breast Cancer. | Clin Breast Cancer | 2024 |
| 36826602 | Hair loss during and after breast cancer therapy. | Support Care Cancer | 2023 |
| 37561108 | Changes in amount and intensity of physical activity over time in breast cancer survivors. | JNCI Cancer Spectr | 2023 |
| 37847317 | A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2. | Support Care Cancer | 2023 |
| 37991653 | Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients. | Support Care Cancer | 2023 |
| 37498410 | Measuring symptoms and toxicities: a 35-year experience. | Support Care Cancer | 2023 |
| 37017603 | A five arm natural history study of nasal vestibulitis. | Cancer Med | 2023 |
| 37284847 | Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602). | Oncologist | 2023 |
| 37467399 | Cancer Cachexia: ASCO Guideline Rapid Recommendation Update. | J Clin Oncol | 2023 |
| 37437145 | Cutaneous Electroanalgesia for Relief of Chronic and Neuropathic Pain. | N Engl J Med | 2023 |
| 36693773 | Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701). | Semin Oncol | 2023 |
| 35267520 | Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months. | Cancers (Basel) | 2022 |
| 35853817 | Surveillance mammography in older breast cancer survivors: Current practice patterns and patient perceptions. | J Geriatr Oncol | 2022 |
| 36534173 | Financial hardship in breast cancer survivors: a prospective analysis of change in financial concerns over time. | Support Care Cancer | 2022 |
| 36525104 | Dietary supplement use and recommendations for discontinuation in an integrative oncology clinic. | Support Care Cancer | 2022 |
| 36214880 | A global survey on the utilization of cryotherapy and compression therapy for the prevention of chemotherapy-induced peripheral neuropathy. | Support Care Cancer | 2022 |
| 36315918 | Slow Uptake of an Effective Therapy: Patterns of Olanzapine Prescribing for Those Receiving Highly Emetogenic Chemotherapy. | JCO Oncol Pract | 2022 |
| 35963481 | ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. | Ann Oncol | 2022 |
| 35953729 | Pregabalin for chemotherapy-induced neuropathy: background and rationale for further study. | Support Care Cancer | 2022 |
| 36122322 | Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline. | J Clin Oncol | 2022 |
| 35946834 | Factors Associated With Physical Activity Levels in Patients With Breast Cancer. | Oncologist | 2022 |
| 35160226 | Long-Term Follow-Up of Fractional CO<sub>2</sub> Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors. | J Clin Med | 2022 |
| 34890259 | A Pill for Sexual Desire in Female Cancer Survivors: Too Good to Be True? | J Clin Oncol | 2022 |
| 34882169 | Efficacy of Treatment With Armodafinil for Cancer-Related Fatigue in Patients With High-grade Glioma: A Phase 3 Randomized Clinical Trial. | JAMA Oncol | 2022 |
| 32372176 | A randomized, double-blind, placebo-controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102. | Support Care Cancer | 2021 |
| 33851235 | Natural history of nasal vestibulitis associated with paclitaxel, docetaxel, and other chemotherapy agents: a Minnesota Cancer Clinical Trials Network (MNCCTN) study. | Support Care Cancer | 2021 |
| 33534429 | Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy. | Menopause | 2021 |
| 33802509 | Genetic Predictors of Chemotherapy-Induced Peripheral Neuropathy from Paclitaxel, Carboplatin and Oxaliplatin: NCCTG/Alliance N08C1, N08CA and N08CB Study. | Cancers (Basel) | 2021 |
| 33578652 | Genetic Variations and Health-Related Quality of Life (HRQOL): A Genome-Wide Study Approach. | Cancers (Basel) | 2021 |
| 34841942 | Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series. | Integr Cancer Ther | 2021 |
| 34480623 | Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724). | Support Care Cancer | 2021 |
| 34176021 | Neuropathy severity at the time of oxaliplatin treatment alteration in patients with colon cancer (Alliance A151912). | Support Care Cancer | 2021 |
| 34174668 | Patient-centric decision framework for treatment alterations in patients with Chemotherapy-induced Peripheral Neuropathy (CIPN). | Cancer Treat Rev | 2021 |
| 34362097 | N-Terminal Pro Brain Natriuretic Peptide, sST2, and Galectin-3 Levels in Breast Cancer Survivors. | J Clin Med | 2021 |
| 33973082 | Does the placebo effect on hot flashes depend on the placebo dose? | Support Care Cancer | 2021 |
| 33249081 | Randomized Trial of Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy: Crossover Analysis. | J Pain Symptom Manage | 2021 |
| 33079411 | A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance). | Cancer | 2021 |
| 33079393 | Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients. | Cancer | 2021 |
| 33473331 | Real-World Experiences With Yoga on Cancer-Related Symptoms in Women With Breast Cancer. | Glob Adv Health Med | 2021 |
| 33358206 | Pilot study of fractional CO<sub>2</sub> laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors. | Maturitas | 2021 |
| 33351067 | Lifestyle Factors Can Lead to Multiple Cancers Over a Lifetime-Here We Go Again. | JAMA Oncol | 2021 |
| 33231809 | Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group. | Support Care Cancer | 2021 |
| 32500206 | Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724). | Support Care Cancer | 2021 |
| 30377210 | Rose geranium in sesame oil nasal spray: a treatment for nasal vestibulitis? | BMJ Support Palliat Care | 2020 |
| 32031887 | Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. | J Palliat Med | 2020 |
| 31811486 | Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors. | Support Care Cancer | 2020 |
| 31836937 | Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. | Support Care Cancer | 2020 |
| 32018185 | Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes. | J Neurol Sci | 2020 |
| 31912795 | Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither? | Ann Oncol | 2020 |